Taiwan Liposome Company, Ltd. Unsponsored ADR Debt to Equity Ratio 2019-2021 | TLC
Current and historical debt to equity ratio values for Taiwan Liposome Company, Ltd. Unsponsored ADR (TLC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Taiwan Liposome Company, Ltd. Unsponsored ADR debt/equity for the three months ending June 30, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-06-30 | $0.03B | $0.02B | 1.40 |
| 2021-03-31 | $0.03B | $0.02B | 1.36 |
| 2020-12-31 | $0.03B | $0.03B | 1.03 |
| 2020-09-30 | $0.03B | $0.03B | 1.06 |
| 2020-06-30 | $0.03B | $0.03B | 0.82 |
| 2020-03-31 | $0.02B | $0.02B | 1.21 |
| 2019-12-31 | $0.02B | $0.02B | 0.92 |
| 2019-09-30 | $0.02B | $0.02B | 0.92 |
| 2019-06-30 | $0.02B | $0.01B | 2.25 |
| 2019-03-31 | $0.03B | $0.02B | 1.48 |
| 2018-12-31 | $0.02B | $0.02B | 1.12 |
| 2018-09-30 | $0.02B | $0.01B | 1.46 |
| 2018-06-30 | $0.02B | $0.02B | 1.07 |
| 2018-03-31 | $0.01B | $0.03B | 0.33 |
